Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors
TransThera Sciences (Nanjing), Inc.
TransThera Sciences (Nanjing), Inc.
Tempest Therapeutics
Quadriga Biosciences, Inc.
Celgene
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
FeRx